初级胆汁酸促进肝癌细胞生长的作用及机制

基本信息
批准号:81872040
项目类别:面上项目
资助金额:25.00
负责人:付政祺
学科分类:
依托单位:江汉大学
批准年份:2018
结题年份:2020
起止时间:2019-01-01 - 2020-12-31
项目状态: 已结题
项目参与者:刘丽江,郑丹,镇鸿燕,陈琼霞,陈辉,熊丹阳
关键词:
肝细胞癌表皮生长因子受体胆酸鹅脱氧胆酸雌激素受体α36
结项摘要

Hepatocellular carcinoma is a malignant tumor common in China, and the underlying mechanism of its development is currently unclear. Previous studies indicated that increased levels of bile acids are closely associated with occurrence of liver cancer. Inspired by our research in gastric cancer, we found that a novel estrogen receptor isoform ER-α36 was highly expressed in human specimens of liver cancer, and was positively correlated with EGFR expression. Primary bile acids exhibited estrogen-like activities in established liver cancer cells. Both cholic acid and chenodesoxycholic acid increased the levels of ER-α36 and EGFR expression, up-regulated ERK phosphorylation and promoted liver cancer cell growth. In the liver cancer cells with knocked-down levels of ER-α36 expression, both cholic acid and chenodesoxycholic acid failed to promote cell growth. These results suggested that primary bile acids might promote growth of liver cancer cells through ER-α36 mediated signaling and the ER-α36-EGFR regulatory loop. Thus, we hypothesized that primary bile acids posses estrogen-like activities, and promote growth of liver cancer cells. In this proposed study, we will study the functions and underlying mechanisms of primary bile acid effects on the ER-α36 signaling and its regulatory loop with EGFR in liver cancer cell growth with experiments including human tissue staining, in vivo animal, in vitro cell/stem cell, protein and gene assays. These results are of great importance in clinical and biological research.

肝细胞癌是我国常见恶性肿瘤,其发生机制目前不清。有研究发现,高浓度初级胆汁酸与肝癌的发生存在关联。申请者受本实验室胃癌研究的启发,在人肝细胞癌组织中发现新型雌激素受体ER-α36和EGFR高表达,并且两者存在正相关,同时发现初级胆汁酸具有类雌激素作用。初步研究显示,胆酸和鹅脱氧胆酸可上调肝癌细胞中ER-α36和EGFR的表达,升高ERK的磷酸化水平,促进细胞生长;而沉默ER-α36的肝癌重组细胞中,则无此现象。提示胆酸和鹅脱氧胆酸可能通过ER-α36介导的信号通路,利用ER-α36-EGFR调节环路,促进肝癌细胞生长。据此,申请者提出了初级胆汁酸具有类雌激素的作用,可促进肝癌细胞生长的全新理论,并拟从人体、动物、肝癌(干)细胞、蛋白及基因水平上获得初级胆汁酸-ER-α36信号通路,ER-α36-EGFR调节环路的作用,促进肝癌细胞生长的机制等大量重要数据,具有重大的临床及生物学意义。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

氟化铵对CoMoS /ZrO_2催化4-甲基酚加氢脱氧性能的影响

氟化铵对CoMoS /ZrO_2催化4-甲基酚加氢脱氧性能的影响

DOI:10.16606/j.cnki.issn0253-4320.2022.10.026
发表时间:2022
2

木薯ETR1基因克隆及表达分析

木薯ETR1基因克隆及表达分析

DOI:10.3969/j.issn.2095-1191.2020.01.003
发表时间:2020
3

C-藻蓝蛋白抑制TGF-β1诱导的宫颈癌Caski细胞上皮-间充质转化

C-藻蓝蛋白抑制TGF-β1诱导的宫颈癌Caski细胞上皮-间充质转化

DOI:10.3872/j.issn.1007-385x.2020.02.005
发表时间:2020
4

乳腺癌内分泌治疗耐药机制的研究进展

乳腺癌内分泌治疗耐药机制的研究进展

DOI:
发表时间:2016
5

基于深度学习的宫颈癌异常细胞快速检测方法

基于深度学习的宫颈癌异常细胞快速检测方法

DOI:10.13374/j.issn2095-9389.2021.01.12.001
发表时间:2021

付政祺的其他基金

批准号:81402315
批准年份:2014
资助金额:23.00
项目类别:青年科学基金项目

相似国自然基金

1

肝癌细胞内高表达的PEDF通过调控脂肪酸代谢促进肝癌生长的作用及机制研究

批准号:81572342
批准年份:2015
负责人:杨霞
学科分类:H1807
资助金额:45.00
项目类别:面上项目
2

增殖抑制基因促进肝癌细胞凋亡及抑制肝癌生长的机制研究

批准号:81172315
批准年份:2011
负责人:王伟林
学科分类:H1801
资助金额:59.00
项目类别:面上项目
3

胆汁酸核受体FXR在肝癌中的作用和分子机制研究

批准号:81472232
批准年份:2014
负责人:陈卫东
学科分类:H1803
资助金额:78.00
项目类别:面上项目
4

NudC在细胞初级纤毛生长调节中的作用及分子机制研究

批准号:31471259
批准年份:2014
负责人:杨月红
学科分类:C0701
资助金额:80.00
项目类别:面上项目